PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+24.47%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.91B
AUM Growth
+$85.7M
(+4.7%)
Cap. Flow
-$225M
Cap. Flow
% of AUM
-11.82%
Top 10 Holdings %
Top 10 Hldgs %
76.45%
Holding
46
New
3
Increased
22
Reduced
1
Closed
5
Top Buys
1 |
Biogen
BIIB
|
+$57.4M |
2 |
BioMarin Pharmaceuticals
BMRN
|
+$37M |
3 |
Acadia Pharmaceuticals
ACAD
|
+$25.1M |
4 |
eHealth
EHTH
|
+$21.6M |
5 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$19.2M |
Top Sells
1 |
IMMU
Immunomedics Inc
IMMU
|
+$413M |
2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
+$28.2M |
3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$1.55M |
4 |
Evolus
EOLS
|
+$1.04M |
5 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
+$682K |
Sector Composition
1 | Healthcare | 97.42% |
2 | Financials | 2.17% |